During the past decade, Japan Cardiovascular Research Foundation conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Japan Cardiovascular Research Foundation" are "Atrial Fibrillation" (3 trials) and "Stroke, Acute" (1 trials). Many other conditions were trialed in "Japan Cardiovascular Research Foundation" in a lesser frequency.

Most popular intervention types in "Japan Cardiovascular Research Foundation" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rivaroxaban" (1 trials), "Rivaroxaban and single antiplatelet drug (aspirin, clopidogrel or prasugrel)" (1 trials) and "This is an observational study" (1 trials). Other intervention names were less common.

The vast majority of trials in "Japan Cardiovascular Research Foundation" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Japan Cardiovascular Research Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Japan Cardiovascular Research Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Japan Cardiovascular Research Foundation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".